{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:19:21Z","timestamp":1788985161535,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Special Key Project of Biosafety Technologies","award":["2017YFC1200902"],"award-info":[{"award-number":["2017YFC1200902"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.imlet.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T04:32:53Z","timestamp":1502253173000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells"],"prefix":"10.1016","volume":"190","author":[{"given":"Bo-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Sheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Zhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Tang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.imlet.2017.08.004_bib0005","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1172\/JCI200422608","article-title":"Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines","volume":"114","author":"Sumida","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.08.004_bib0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T Cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.08.004_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2011.02496.x","article-title":"Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity","volume":"271","author":"Trumpfheller","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.imlet.2017.08.004_bib0020","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.molimm.2004.09.034","article-title":"Single chain antibody fragments for the selective targeting of antigens to dendritic cells","volume":"42","author":"Demangel","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2017.08.004_bib0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1900\/RDS.2012.9.305","article-title":"Targeted antigen delivery to DEC-205+ dendritic cells for tolerogenic vaccination","volume":"9","author":"Petzold","year":"2012","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.imlet.2017.08.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008068","article-title":"Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205","volume":"6","author":"Dhodapkar","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2017.08.004_bib0035","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood-2010-06-288068","article-title":"Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody","volume":"116","author":"Cheong","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.08.004_bib0040","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1073\/pnas.1505924112","article-title":"pH-Dependent recognition of apoptotic and necrotic cells by the human dendritic cell receptor DEC205","volume":"112","author":"Cao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.08.004_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2011.12.009","article-title":"Generation of anti-human DEC205\/CD205 monoclonal antibodies that recognize epitopes conserved in different mammals","volume":"377","author":"Park","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imlet.2017.08.004_bib0050","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/S0264-410X(03)00260-3","article-title":"DNA vaccination protects against botulinum neurotoxin type F","volume":"21","author":"Bennett","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.08.004_bib0055","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/21645515.2015.1066051","article-title":"DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge","volume":"11","author":"Scott","year":"2015","journal-title":"Hum. Vaccine Immunother."},{"key":"10.1016\/j.imlet.2017.08.004_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10408410590912952","article-title":"Clostridium botulinum: a bug with beauty and weapon","volume":"31","author":"Shukla","year":"2005","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.imlet.2017.08.004_bib0065","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1016\/j.vaccine.2007.10.016","article-title":"Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A","volume":"25","author":"Yu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.08.004_bib0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jviromet.2012.11.035","article-title":"Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system","volume":"189","author":"Villaflores","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.imlet.2017.08.004_bib0075","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1038\/srep07678","article-title":"Characterization and immunological activity of different forms of recombinant secreted Hc of botulinum neurotoxin serotype B products expressed in yeast","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2017.08.004_bib0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.anaerobe.2014.06.003","article-title":"Production of recombinant botulism antigens: a review of expression systems","volume":"28","author":"Moreira","year":"2014","journal-title":"Anaerobe"},{"key":"10.1016\/j.imlet.2017.08.004_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-4-33","article-title":"Recombinant production of bacterial toxins and their derivatives in the methylotrophic yeast Pichia pastoris","volume":"4","author":"Gurkan","year":"2005","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.imlet.2017.08.004_bib0090","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0264-410X(99)00253-4","article-title":"Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A","volume":"18","author":"Clayton","year":"2000","journal-title":"Vccine"},{"key":"10.1016\/j.imlet.2017.08.004_bib0095","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1016\/j.vaccine.2009.08.022","article-title":"Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors","volume":"27","author":"Yu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.08.004_bib0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/08923970802713470","article-title":"Improved immunogenicity and protective efficacy of a replicon DNA vaccine encoding the Hc domain of botulinum neurotoxin serotype A by electric pulses and protein boosting","volume":"31","author":"Yu","year":"2009","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.imlet.2017.08.004_bib0105","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1016\/j.vaccine.2010.08.107","article-title":"Distinct immune responses of recombinant plasmid DNA replicon vaccines expressing two types of antigens with or without signal sequences","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.08.004_bib0110","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L","article-title":"Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens","volume":"28","author":"Kim","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2017.08.004_bib0115","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1172\/JCI34224","article-title":"The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells","volume":"118","author":"Nchinda","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.08.004_bib0120","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.vaccine.2011.12.110","article-title":"CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4+ T cell responses following DNA vaccination of outbred animals","volume":"30","author":"Njongmeta","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.imlet.2017.08.004_bib0125","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.20032220","article-title":"In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination","volume":"199","author":"Bonifaz","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.08.004_bib0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2014.07.004","article-title":"Targeting human dendritic cells in situ to improve vaccines","volume":"162","author":"Sehgal","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2017.08.004_bib0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4161\/hv.22888","article-title":"Enhanced potency of replicon vaccine using one vector to simultaneously co-express antigen and interleukin-4 molecular adjuvant","volume":"9","author":"Ma","year":"2014","journal-title":"Hum. Vaccine Immunother."},{"key":"10.1016\/j.imlet.2017.08.004_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.08.004_bib0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/08923971003782327","article-title":"Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant","volume":"33","author":"Li","year":"2011","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.imlet.2017.08.004_bib0150","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1128\/IAI.00166-11","article-title":"Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells","volume":"79","author":"White","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imlet.2017.08.004_bib0155","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/jvh.12542","article-title":"Enhanced immunity and antiviral effects of an HBV DNA vaccine delivered by a DC-targeting protein","volume":"23","author":"Wang","year":"2016","journal-title":"Viral. Hepat."},{"key":"10.1016\/j.imlet.2017.08.004_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-14-39","article-title":"DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice","volume":"14","author":"Cao","year":"2013","journal-title":"BMC Immunol."},{"key":"10.1016\/j.imlet.2017.08.004_bib0165","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/cti.2016.6","article-title":"Targeting dendritic cells: a promising strategy to improve vaccine effectiveness","volume":"5","author":"Macri","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.imlet.2017.08.004_bib0170","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/CVI.00493-09","article-title":"Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B","volume":"17","author":"Held","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.imlet.2017.08.004_bib0175","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2009.02.091","article-title":"The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate","volume":"27","author":"Yu","year":"2009","journal-title":"Vaccine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T13:23:14Z","timestamp":1535462594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817302699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":35,"alternative-id":["S0165247817302699"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.08.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}